Business Context and Reporting Period
This Form 8-K was filed by Illumina, Inc. on October 5, 2022. The report addresses a disclosure made during an Investor Day event held on October 3, 2022, which included a live webcast and Q&A session.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a regulatory disclosure regarding a specific operational metric correction.
Material Changes and Corrections
The filing corrects an inaccurate statement made during the October 3, 2022, Investor Day event:
- Inaccurate Statement: The number of high throughput customers was cited as 1,500.
- Corrected Metric: The total installed base of NovaSeq instruments as of the end of the second fiscal quarter of 2022 is more than 1,700.
Guidance, Outlook, and Risks
The filing does not provide new financial guidance, outlook, or management commentary beyond the correction of the installed base figure. It explicitly states that the information furnished is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the corrected NovaSeq installed base figure (>1,700) against the company's most recent quarterly earnings report (Q2 2022).
- Confirm that this 8-K is a Regulation FD disclosure and does not constitute a formal filing of financial data.
- Review the original Investor Day presentation materials to understand the context of the initial error.